专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

91. 发明申请

US20030038082A1 Process for the purification of organometallic compounds or heteroatomic organic compounds with hydrogenated getter alloys 失效
标题翻译：用氢化吸气剂合金纯化有机金属化合物或杂原子有机化合物的方法
公开(公告)号：US20030038082A1
公开(公告)日：2003-02-27
申请号：US10273862
申请日：2002-10-18
申请人： SAES GETTERS S.p.A.
发明人： Giorgio Vergani , Marco Succi
IPC分类号： B01D015/08
CPC分类号： B01D53/02 , B01D53/04 , B01D2256/12 , B01D2257/706 , B01D2257/80 , B01D2258/0216 , B01J20/02 , B01J20/18 , C07F1/00 , C07F1/005 , C07F3/00 , C07F3/10 , C07F5/00 , C07F5/062 , C07F5/064 , C07F5/065 , C07F5/066 , C07F7/003 , C07F7/2208 , C07F9/90 , C07F9/94 , C07F17/00 , C07F17/02 , C23C16/18 , C23C16/4402
摘要： A process for the purification of organometallic compounds or heteroatomic organic compounds from oxygen, water and from the compounds deriving from the reaction of water and oxygen with the organometallic or heteroatomic compounds whose purification is sought, comprising the operation of contacting the organometallic or heteroatomic compound to be purified in the liquid state or in form of vapor, pure or in a carrier gas, with a hydrogenated getter alloy, and optionally also with one or more gas sorber materials selected among palladium on porous supports and a mixture of iron and manganese supported on zeolites.
摘要翻译：从氧，水和衍生自水和氧的反应的化合物与要求纯化的有机金属或杂原子化合物纯化有机金属化合物或杂原子有机化合物的方法，包括使有机金属或杂原子化合物与以液态或蒸汽形式纯化或在载气中用氢化吸气剂合金，以及任选地还可以选择一种或多种选自多孔载体上的钯和负载在铁上的铁和锰的混合物的气体吸附剂材料沸石。

92. 发明授权

US06492540B1 Solventless nontoxic high refraction index and low birefringence organic/inorganic hybrid materials 失效
$Solventless nontoxic high refraction index and low birefringence organic/inorganic hybrid materials$
标题翻译：无溶剂无毒高折射率和低双折射有机/无机杂化材料
公开(公告)号：US06492540B1
公开(公告)日：2002-12-10
申请号：US09571597
申请日：2000-05-15
申请人： Wei-Fang Su , Hsiao-Kuan Yuan
发明人： Wei-Fang Su , Hsiao-Kuan Yuan
IPC分类号： C07F728
CPC分类号： C08K5/098 , C07C69/54 , C07F7/003 , C07F9/94 , C08F2/44
摘要： Enclosed are high refractive index and low birefringence organic/inorganic hybrid materials useful for optical applications. They are prepared from solventless metal aliphatic acryl alkoxides. The metal acryl alkoxides are synthesized from exchanging acryl alcohol with metal alkoxides, and are hydrolyzed into metal oxide nanoparticles and are well dispersed in the acrylate matrix. Then they are polymerized into organic/inorganic hybrid materials containing metal oxide in polyacrylate.
摘要翻译：封闭的是高折射率和低双折射有机/无机混合材料，可用于光学应用。它们由无溶剂金属脂族丙烯酸醇盐制备。金属丙烯酸烷氧化物由丙烯醇与金属醇盐交换而合成，并被水解成金属氧化物纳米粒子，并且分散在丙烯酸酯基体中。然后将它们聚合成在聚丙烯酸酯中含有金属氧化物的有机/无机杂化材料。

93. 发明授权

US06482865B1 Method for preparing colloidal solution of bismuth sodium tartrate 失效
标题翻译：酒石酸铋钠胶体溶液的制备方法
公开(公告)号：US06482865B1
公开(公告)日：2002-11-19
申请号：US09547704
申请日：2000-04-12
申请人： Fernando Palafox, Sr.
发明人： Fernando Palafox, Sr.
IPC分类号： B01F312
CPC分类号： A61K9/0095 , A61K31/191 , A61K31/29 , A61K33/245 , C07F9/94 , Y10S514/819
摘要： A method for preparation of a semitransparent colloidal solution of bismuth sodium tartrate generally comprises producing an aqueous solution of bismuth sodium tartrate; extracting a magma of bismuth sodium tartrate from the aqueous solution at a pH of approximately 2.2; and then dissolving the magma into a salting-in mixture. It is critical that the magma be extracted at a pH of at least 2.2 but not more than 2.3. As a result, the magma is extracted by washing with a wash liquor comprising an addition of distilled water; allowing the magma to settle out of the wash liquor; measuring the pH of the wash liquor after the magma has settled; and then decanting the wash liquor from the magma. This process is then repeated as necessary to arrive at a magma within the critical pH range, whereafter the magma is air dried in preparation for salting-in. After addition of preservative and strength testing, the base solution is diluted to an elixir strength. In order to maintain the semitransparent nature of the elixir, however, it is necessary to buffer the elixir to a pH range of about 7.2 to about 7.3.
摘要翻译：酒石酸铋钠半透明胶体溶液的制备方法一般包括制备酒石酸铋钠水溶液; 在大约2.2的pH下从水溶液中提取酒石酸铋钠的岩浆; 然后将岩浆溶解成盐析混合物。在至少2.2但不超过2.3的pH下提取岩浆是至关重要的。结果，通过用包含蒸馏水的洗涤液洗涤来提取岩浆; 允许岩浆从洗涤液中沉淀出来; 在岩浆沉降后测量洗涤液的pH值; 然后从岩浆中滗出洗涤液。然后根据需要重复该过程以在临界pH范围内到达岩浆，此后将岩浆风干以准备盐析。加入防腐剂和强度试验后，将碱溶液稀释至酏剂强度。然而，为了保持酏剂的半透明性质，必须将酏剂缓冲至约7.2至约7.3的pH范围。

94. 发明授权

US06448447B1 Fluoroborate salts comprising a reactive cation and uses thereof 失效
标题翻译：包含反应性阳离子的氟硼酸盐及其用途
公开(公告)号：US06448447B1
公开(公告)日：2002-09-10
申请号：US09704270
申请日：2000-10-31
申请人： Steven H. Strauss , Sergei V. Ivanov
发明人： Steven H. Strauss , Sergei V. Ivanov
IPC分类号： C07F502
CPC分类号： B01J27/08 , C07C17/206 , C07C17/21 , C07F5/027 , C07F5/062 , C07F9/70 , C07F9/90 , C07F9/94 , C07C19/10
摘要： The present invention provides weakly coordinating anion salts comprising a reactive cation and uses thereof. In particular, the present invention provides compounds of the formula MxQy and uses thereof. Preferably, each M is independently a cation with at least one M being a reactive cation as defined herein. Q is a fluorinated polyhedral borate moiety. And x and y are absolute values of the oxidation states of Q and M, respectively.
摘要翻译：本发明提供了包含反应性阳离子的弱配位阴离子盐及其用途。特别地，本发明提供式MxQy的化合物及其用途。优选地，每个M独立地是阳离子，至少一个M是如本文所定义的反应性阳离子。 Q是氟化多面体硼酸盐部分。而x和y分别是Q和M的氧化态的绝对值。

95. 发明授权

US06303101B1 Bismuth compounds 失效
标题翻译：铋化合物
公开(公告)号：US06303101B1
公开(公告)日：2001-10-16
申请号：US09473100
申请日：1999-12-28
申请人： Jo Klaveness , Arne Berg , Torsten Almen , Klaes Golman , Michael Droege , Shi-bao Yu
发明人： Jo Klaveness , Arne Berg , Torsten Almen , Klaes Golman , Michael Droege , Shi-bao Yu
IPC分类号： A61K4900
CPC分类号： A61K49/04 , A61K49/0433 , C07F9/94
摘要： The use in diagnostic imaging, in particular X-ray, MRI, ultrasound and scintigraphy, of contrast agents comprising bismuth clusters and/or organic bismuth compounds, and contrast media containing such bismuth compounds. The bismuth compounds are also useful in therapy, in particular as antimicrobial agents and antiulcer agents. Novel bismuth compounds are also disclosed.
摘要翻译：用于包含铋簇和/或有机铋化合物的造影剂的诊断成像，特别是X射线，MRI，超声和闪烁扫描，以及含有这种铋化合物的造影剂。铋化合物也可用于治疗，特别是抗微生物剂和抗溃疡剂。还公开了新颖的铋化合物。

96. 发明授权

US6039931A Derivatized DTPA complexes, pharmaceutical agents containing these compounds, their use, and processes for their production 失效
标题翻译：衍生的DTPA复合物，含有这些化合物的药剂，其用途及其生产方法
公开(公告)号：US6039931A
公开(公告)日：2000-03-21
申请号：US319357
申请日：1994-10-06
申请人： Heribert Schmitt-Willich , Johannes Platzek , Heinz Gries , Gabrielle Schumann-Giampieri , Hanns-Joachim Weinmann , Hubert Vogler , Julius Deutsch , Juergen Conrad
发明人： Heribert Schmitt-Willich , Johannes Platzek , Heinz Gries , Gabrielle Schumann-Giampieri , Hanns-Joachim Weinmann , Hubert Vogler , Julius Deutsch , Juergen Conrad
IPC分类号： A61K49/04 , A61K49/06 , C07C229/16 , C07F5/00 , C07F9/94 , C07F15/02 , A61K49/00
CPC分类号： A61K49/04 , A61K49/06 , C07C229/16 , C07F15/025 , C07F5/003 , C07F9/94
摘要： Compounds of general Formula I ##STR1## wherein Z.sup.1 and Z.sup.2 in each case independently mean the residue--(CH.sub.2).sub.m --(C.sub.6 H.sub.4).sub.q --(O).sub.k --(CH.sub.2).sub.n --(C.sub.6 H.sub.4).sub.l --(O).sub.r --R, whereinm and n means the numbers 0-20,k, l, q and r means the numbers 0 and 1, andR means a hydrogen atom, an optionally OR.sup.1 -substituted C.sub.1 -C.sub.6 -alkyl residue, or a CH.sub.2 COOR.sup.1 group with R.sup.1 meaning it hydrogen atom, a C.sub.1 -C.sub.6 -alkyl residue, or a benzyl group,X means a hydrogen atom and/or a metal ion equivalent of an element of atomic number 21-29, 42, 44 or 57-83,with the provisos that at least two the substituents X stand for a metal ion equivalent; that one of the substituents Z.sup.1 and Z.sup.2 stands for a hydrogen and the other is not H; that--if n and l each mean the number 0--k and r do not simultaneously mean the number 1; that --(O).sub.r --R is not --OH; and that Z.sup.1 and Z.sup.2 are not --CH.sub.2 --C.sub.6 H.sub.4 --O--CH.sub.2 --COOCH.sub.2 C.sub.6 H.sub.5 or --CH.sub.2 --C.sub.6 H.sub.4 --O--(CH.sub.2).sub.5 --COOCH.sub.2 C.sub.6 H.sub.5, as well as their salts with inorganic and/or organic bases, amino acids or amino acid amides, are valuable pharmaceutical agents, e.g., for NMR.
摘要翻译：其中Z 1和Z 2在每种情况下独立地表示残基 - （CH 2）m - （C 6 H 4）q - （O）k - （CH 2）n - （C 6 H 4）1 - （O）r R的通式I的化合物，其中m和 n表示数字0-20，k，l，q和r表示数字0和1，R表示氢原子，任选OR 1取代的C 1 -C 6烷基残基或具有R 1的CH 2 COOR 1基团，表示氢原子，C1-C6烷基残基或苄基，X表示原子序数21-29,42,44或57-83的元素的氢原子和/或金属离子当量，条件是在至少两个取代基X代表金属离子当量; 取代基Z1和Z2之一代表氢，而另一个不是H; 如果n和l每个意味着数字0-k，r不同时表示数字1; - （O）r-R不是-OH; 并且Z1和Z2不是-CH2-C6H4-O-CH2-COOCH2C6H5或-CH2-C6H4-O-（CH2）5-COOCH2C6H5，以及它们与无机和/或有机碱，氨基酸或氨基酸的盐酰胺，是有价值的药剂，例如核磁共振。

97. 发明授权

US5939045A Organic bismuth derivatives for X-ray imaging 失效
标题翻译：有机铋衍生物用于X射线成像
公开(公告)号：US5939045A
公开(公告)日：1999-08-17
申请号：US860320
申请日：1997-07-18
申请人： Hitomi Suzuki , Keizo Tanikawa , Katsuaki Miyaji , Nobuhiro Suzuki
发明人： Hitomi Suzuki , Keizo Tanikawa , Katsuaki Miyaji , Nobuhiro Suzuki
IPC分类号： A61K49/04 , C07F9/94
CPC分类号： C07F9/94 , A61K49/04 , Y10S424/90
摘要： An organic bismuth derivative represented by formula (I) or its salt: �wherein X.sup.1 is YNR.sup.1 R.sup.2 (wherein Y is --SO.sub.2 -- or --C(O)--, R.sup.1 is a C.sub.3-6 alkyl group which have from 2 to 5 hydroxyl groups which may be protected, and R.sup.2 is a hydrogen atom, a C.sub.1-6 alkyl group or a C.sub.1-5 acyl group which may have from 1 to 5 hydroxyl groups which may be protected, or R.sup.1 and R.sup.2, together with each other, represent a C.sub.2-6 cyclic alkylene which may have from 1 to 4 hydroxyl groups which may be protected), and each of X.sup.2 and X.sup.3 is, independently of each other, a hydrogen atom, a C.sub.1-4 alkyl group, a C.sub.1-4 alkoxy group, a C.sub.1-4 alkylsulfonyl group, a C.sub.1-4 alkylcarbonyl group, a nitro group, a cyano group or the same as defined for X.sup.1 !.
摘要翻译： PCT No.PCT / JP95 / 02551 Sec。 371日期1997年7月18日 102（e）1997年7月18日PCT 1995年12月13日PCT PCT。 WO96 / 19487 PCT出版物日期：1996年6月27日由式（I）表示的有机铋衍生物或其盐：[其中X1为YNR1R2（其中Y为-SO2-或-C（O） - ，R1为C3-6烷基， 2〜5个可被保护的羟基，R2是氢原子，可以具有1〜5个可被保护的羟基的C1-6烷基或C1-5酰基，或者R1和R2一起彼此表示可以具有1〜4个可被保护的羟基的C 2-6环状亚烷基，X2和X3各自独立地为氢原子，C1-4烷基， C 1-4烷氧基，C 1-4烷基磺酰基，C 1-4烷基羰基，硝基，氰基或与X 1所定义的相同]。

98. 发明授权

US5902639A Method of forming bismuth-containing films by using bismuth amide compounds 失效
标题翻译：通过使用铋酰胺化合物形成含铋膜的方法
公开(公告)号：US5902639A
公开(公告)日：1999-05-11
申请号：US828566
申请日：1997-03-31
申请人： Timothy E. Glassman , Gautam Bhandari , Thomas H. Baum
发明人： Timothy E. Glassman , Gautam Bhandari , Thomas H. Baum
IPC分类号： C07F9/94 , C23C16/40 , G02F1/00 , G02F1/05 , C23C16/00
CPC分类号： G02F1/0027 , C07F9/94 , C23C16/40 , C23C16/407 , G02F1/0541 , G02F2203/12
摘要： A method of forming a bismuth-containing material layer on a substrate, comprising bubbler delivery or liquid delivery vaporization of a bismuth amide source reagent to form a bismuth-containing source vapor, and deposition on the substrate of bismuth from the bismuth-containing source vapor, to form the bismuth-containing material layer on the substrate. The bismuth amide source reagent may include a bismuth amide compound of the formula BiL.sup.1.sub.x L.sup.2.sub.y (NR.sup.1 R.sub.2).sub.z wherein: z is an integer of from 1 to 3; x+y+z=3; each of L.sup.1 and L.sup.2 is independently selected from C.sub.1 -C.sub.4 alkyl, C.sub.1 14 C.sub.4 alkoxide, .beta.-diketonate, cyclic amido, cyclic tris-alkoxoamine, and C.sub.6 -C.sub.10 aryl; and each of R.sup.1 and R.sup.2 is independently selected from C.sub.1 -C.sub.8 alkyl, C.sub.1 -C.sub.8 alkoxy, C.sub.6 -C.sub.8 cycloalkyl, C.sub.6 -C.sub.10 aryl, C.sub.1 -C.sub.4 carboxyl, and --SiR.sup.3.sub.3 wherein each R.sup.3 is independently selected from H and C.sub.1 -C.sub.4 alkyl. Bismuth-containing films of the invention may be utilized in the construction of spatial light modulator devices, as buffer layers for the fabrication of ferroelectric material devices, and in dielectric, ferroelectric and superconductor thin film applications.
摘要翻译：一种在基板上形成含铋材料层的方法，包括用于形成含铋源源蒸气的铋酰胺源试剂的起泡器输送或液体输送蒸发，以及从含铋源源蒸气在铋基底上沉积以在基板上形成含铋材料层。铋酰胺源试剂可以包括式BiL1xL2y（NR1R2）z的铋酰胺化合物其中：z是1至3的整数; x + y + z = 3; L1和L2各自独立地选自C 1 -C 4烷基，C 11-14 C 4醇盐，β-二酮酸盐，环状酰胺基，环状三烷氧基胺和C 6 -C 10芳基; R 1和R 2各自独立地选自C 1 -C 8烷基，C 1 -C 8烷氧基，C 6 -C 8环烷基，C 6 -C 10芳基，C 1 -C 4羧基和-SiR 33，其中每个R 3独立地选自H和C 1 -C 4 烷基。本发明的含铋膜可用于构造空间光调制器件，作为用于制造铁电材料器件的缓冲层，以及介电，铁电和超导体薄膜应用。

99. 发明授权

US5846519A Method for imaging mammalian tissue using 1-substituted-1,4,7-tricarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs 失效
公开(公告)号：US5846519A
公开(公告)日：1998-12-08
申请号：US471591
申请日：1995-06-06
申请人： Michael F. Tweedle , Glen T. Gaughan , James J. Hagan
发明人： Michael F. Tweedle , Glen T. Gaughan , James J. Hagan
IPC分类号： A61K49/06 , A61K51/04 , C07B59/00 , C07D255/02 , C07D257/00 , C07D257/02 , C07D273/00 , C07F5/00 , C07F9/94 , C07F11/00 , C07F13/00 , C07F15/02 , A61B5/055
CPC分类号： A61K49/06 , A61K51/0476 , A61K51/0482 , C07B59/002 , C07D257/00 , C07D257/02 , C07D273/00 , C07F11/005 , C07F13/005 , C07F15/025 , C07F5/003 , C07F9/94 , Y10S436/806 , Y10S514/836 , Y10T436/24
摘要： A method for imaging mammalian tissue utilizing a non-ionic complex of a paramagnetic ion of lanthanide element and a macrocyclic chelating agent.

100. 发明授权

US5730953A Tris(substituted phenyl) bismuth derivatives 失效
标题翻译：三（取代苯基）铋衍生物
公开(公告)号：US5730953A
公开(公告)日：1998-03-24
申请号：US596371
申请日：1996-03-19
申请人： Hitomi Suzuki , Koichi Maeda , Keizo Tanikawa , Katsuaki Miyaji
发明人： Hitomi Suzuki , Koichi Maeda , Keizo Tanikawa , Katsuaki Miyaji
IPC分类号： A61K49/04 , C07F9/94
CPC分类号： A61K49/04 , C07F9/94 , Y10S424/90
摘要： tris(substituted phenyl) bismuth compounds of formula (I) and pharmaceutically acceptable salts thereof are useful x-ray radiographic imaging agents: ##STR1## wherein X.sub.1, X.sub.2 and X.sub.3 are as defined in the specification.
摘要翻译： PCT No.PCT / JP94 / 01381 Sec。 371日期：1996年3月19日 102（e）1996年3月19日PCT PCT 1994年8月22日PCT公布。公开号WO95 / 06053 日期1995年3月2日式（I）的三（（取代苯基）铋）铋化合物及其药学上可接受的盐是有用的x射线照相成像剂：其中X 1，X 2和X 3如说明书中所定义。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式